BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 28170118)

  • 1. Image-guided interstitial high-dose-rate brachytherapy in the treatment of inoperable recurrent head and neck malignancies: An effective option of reirradiation.
    Tselis N; Karagiannis E; Kolotas C; Baghi M; Milickovic N; Zamboglou N
    Head Neck; 2017 Apr; 39(4):E61-E68. PubMed ID: 28170118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reirradiation for recurrent neck metastases of head-and-neck tumors using CT-guided interstitial 192Ir HDR brachytherapy.
    Kolotas C; Tselis N; Sommerlad M; Röddiger S; Schnabel T; Baltas D; Kalogera-Fountzila A; Fountzilas G; Zamboglou N
    Strahlenther Onkol; 2007 Feb; 183(2):69-75. PubMed ID: 17294110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypofractionated accelerated CT-guided interstitial ¹⁹²Ir-HDR-Brachytherapy as re-irradiation in inoperable recurrent cervical lymphadenopathy from head and neck cancer.
    Tselis N; Ratka M; Vogt HG; Kolotas C; Baghi M; Baltas D; Fountzilas G; Georgoulias V; Ackermann H; Zamboglou N
    Radiother Oncol; 2011 Jan; 98(1):57-62. PubMed ID: 21129799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer.
    Hepel JT; Syed AM; Puthawala A; Sharma A; Frankel P
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1444-50. PubMed ID: 16029806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT-guided interstitial HDR-brachytherapy for recurrent glioblastoma multiforme: a 20-year single-institute experience.
    Chatzikonstantinou G; Zamboglou N; Archavlis E; Strouthos I; Zoga E; Milickovic N; Hilaris B; Baltas D; Rödel C; Tselis N
    Strahlenther Onkol; 2018 Dec; 194(12):1171-1179. PubMed ID: 30203110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeat re-irradiation with interstitial HDR-brachytherapy for an in-field isolated nodal recurrence in a patient with HPV-positive squamous cell carcinoma of the head and neck.
    Kim JK; Hardy-Abeloos C; Purswani JM; Kamen E; Concert CM; Duckworth T; Tam M; Haas J; Rybstein M; Vaezi A; Jacobson A; Hu KS
    Brachytherapy; 2023; 22(4):503-511. PubMed ID: 36593130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interstitial HDR brachytherapy for advanced recurrent squamous cell carcinoma of the head and neck.
    Wiegand S; Sesterhenn AM; Zimmermann AP; Strassmann G; Wilhelm T; Werner JA
    Anticancer Res; 2013 Jan; 33(1):249-52. PubMed ID: 23267152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for head-and-neck carcinoma.
    Nag S; Cano ER; Demanes DJ; Puthawala AA; Vikram B;
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1190-8. PubMed ID: 11483328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interstitial low-dose-rate brachytherapy as a salvage treatment for recurrent head-and-neck cancers: long-term results.
    Puthawala A; Nisar Syed AM; Gamie S; Chen YJ; Londrc A; Nixon V
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):354-62. PubMed ID: 11567809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Customized individual applicators for endocavitary brachytherapy in patients with cancers of the nasal cavity, sinonasal region and nasopharynx.
    Kadah BA; Niewald M; Papaspyrou G; Dzierma Y; Schneider M; Schick B
    Eur Arch Otorhinolaryngol; 2016 Jun; 273(6):1543-7. PubMed ID: 25905695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative HDR brachytherapy for reirradiation in head and neck recurrences: single-institution experience and systematic review.
    Tagliaferri L; Bussu F; Fionda B; Catucci F; Rigante M; Gambacorta MA; Autorino R; Mattiucci GC; Miccichè F; Placidi E; Balducci M; Galli J; Paludetti G; Kovacs G; Valentini V
    Tumori; 2017 Nov; 103(6):516-524. PubMed ID: 28291904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reirradiation of head and neck cancer: Long-term disease control and toxicity.
    Bots WTC; van den Bosch S; Zwijnenburg EM; Dijkema T; van den Broek GB; Weijs WLJ; Verhoef LCG; Kaanders JHAM
    Head Neck; 2017 Jun; 39(6):1122-1130. PubMed ID: 28263446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose-rate brachytherapy in the treatment of recurrent and residual head and neck cancer.
    Glatzel M; Büntzel J; Schröder D; Küttner K; Fröhlich D
    Laryngoscope; 2002 Aug; 112(8 Pt 1):1366-71. PubMed ID: 12172246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CT-guided interstitial HDR brachytherapy for recurrent glioblastoma multiforme. Long-term results.
    Tselis N; Kolotas C; Birn G; Röddiger S; Filipowicz I; Kontova M; Fountzilas G; Selviaridis P; Baltas D; Heyd R; Anagnostopoulos G; Zamboglou N
    Strahlenther Onkol; 2007 Oct; 183(10):563-70. PubMed ID: 17896088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of CT-guided
    Chen Y; Jiang Y; Ji Z; Jiang P; Xu F; Zhang Y; Guo F; Peng R; Li X; Sun H; Lei R; Fan J; Li W; Wang J
    Brachytherapy; 2020; 19(1):81-89. PubMed ID: 31653566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head and neck cancer reirradiation with interstitial high-dose-rate brachytherapy.
    Hegde JV; Demanes DJ; Veruttipong D; Chin RK; Park SJ; Kamrava M
    Head Neck; 2018 Jul; 40(7):1524-1533. PubMed ID: 29573121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reirradiation for recurrent head and neck carcinoma using high-dose-rate brachytherapy: A multi-institutional study.
    Yamazaki H; Masui K; Suzuki G; Yoshida K; Nakamura S; Isohashi F; Kotsuma T; Takaoka Y; Tanaka E; Akiyama H; Ishibashi N
    Brachytherapy; 2022; 21(3):341-346. PubMed ID: 35307301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of Re-irradiation using carbon ions for recurrent head and neck malignancies after carbon-ion radiotherapy.
    Hayashi K; Koto M; Ikawa H; Hagiwara Y; Tsuji H; Ogawa K; Kamada T
    Radiother Oncol; 2019 Jul; 136():148-153. PubMed ID: 31015117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.
    Romesser PB; Cahlon O; Scher ED; Hug EB; Sine K; DeSelm C; Fox JL; Mah D; Garg MK; Han-Chih Chang J; Lee NY
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):386-395. PubMed ID: 27084656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reirradiation for patients with recurrence head and neck squamous cell carcinoma: a single-institution comparative study.
    Rudžianskas V; Inčiūra A; Vaitkus S; Padervinskis E; Rudžianskienė M; Kupčinskaitė-Noreikienė R; Saltonaitė L; Noreika A; Statnickaitė A; Juozaitytė E
    Medicina (Kaunas); 2014; 50(2):92-9. PubMed ID: 25172603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.